Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment.
Bushnell D, Menda Y, O'Dorisio T, Madsen M, Miller S, Carlisle T, Squires S, Kahn D, Walkner W, Connolly M, O'Dorisio S, Karwal M, Ponto J, Bouterfa H. Bushnell D, et al. Among authors: madsen m. Cancer Biother Radiopharm. 2004 Feb;19(1):35-41. doi: 10.1089/108497804773391658. Cancer Biother Radiopharm. 2004. PMID: 15068609 Clinical Trial.
Assessment of hepatic toxicity from treatment with 90Y-SMT 487 (OctreoTher(TM)) in patients with diffuse somatostatin receptor positive liver metastases.
Bushnell D, Menda Y, Madsen M, O'Dorisio T, Carlisle T, Zehr P, Ponto L, Karwal M, Parker S, Ponto J, Connolly M, Bouterfa H. Bushnell D, et al. Among authors: madsen m. Cancer Biother Radiopharm. 2003 Aug;18(4):581-8. doi: 10.1089/108497803322287664. Cancer Biother Radiopharm. 2003. PMID: 14503953 Clinical Trial.
Potential for Increasing Uptake of Radiolabeled 68Ga-DOTATOC and 123I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat.
Pollard JH, Menda Y, Zamba KD, Madsen M, O'Dorisio MS, O'Dorisio T, Bushnell D. Pollard JH, et al. Among authors: madsen m. Cancer Biother Radiopharm. 2021 Oct;36(8):632-641. doi: 10.1089/cbr.2020.4633. Epub 2021 Jul 12. Cancer Biother Radiopharm. 2021. PMID: 34252288 Free PMC article.
99mTc-depreotide tumour uptake in patients with non-Hodgkin's lymphoma.
Bushnell DL, Menda Y, Madsen MT, Link BK, Kahn D, Truhlar SM, Juweid M, Shannon M, Murguia JS. Bushnell DL, et al. Among authors: madsen mt. Nucl Med Commun. 2004 Aug;25(8):839-43. doi: 10.1097/01.mnm.0000126628.01919.f9. Nucl Med Commun. 2004. PMID: 15266180 Clinical Trial.
90Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy.
Menda Y, Madsen MT, O'Dorisio TM, Sunderland JJ, Watkins GL, Dillon JS, Mott SL, Schultz MK, Zamba GKD, Bushnell DL, O'Dorisio MS. Menda Y, et al. Among authors: madsen mt. J Nucl Med. 2018 Nov;59(11):1692-1698. doi: 10.2967/jnumed.117.202903. Epub 2018 Mar 9. J Nucl Med. 2018. PMID: 29523629 Free PMC article. Clinical Trial.
1,470 results